Novel inhibitors of the calcineurin/NFATc hub - Alternatives to CsA and FK506?

Cell Communication and Signaling

Volumn 7, Issue , 2009, Pages

  Sieber, Matthias ^a   Baumgrass, Ria ^a  

^a DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72849149270     PISSN: 1478811X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1478-811X-7-25     Document Type: Review

References (198)

1. Purification of cyclic 3',5'-nucleotide phosphodiesterase inhibitory protein by affinity chromatography on activator protein coupled to Sepharose. CB Klee MH Krinks, Biochemistry 1978 17 120 126
2. NFAT signaling: choreographing the social lives of cells. GR Crabtree EN Olson, Cell 2002 109 Suppl 67 79
3. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. CB Klee H Ren X Wang, J Biol Chem 1998 273 13367 13370
4. Endogenous protein inhibitors of calcineurin. JO Liu, Biochem Biophys Res Commun 2003 311 1103 1109
5. Calmodulin-dependent phosphatase, kinases, and transcriptional corepressors involved in T-cell activation. JO Liu, Immunol Rev 2009 228 184 198
6. Potential role of calcineurin for brain ischemia and traumatic injury. M Morioka J Hamada Y Ushio E Miyamoto, Prog Neurobiol 1999 58 1 30
7. Transcription factors of the NFAT family: regulation and function. A Rao C Luo PG Hogan, Annu Rev Immunol 1997 15 707 747
8. The role of NF-AT transcription factors in T cell activation and differentiation. E Serfling F Berberich-Siebelt S Chuvpilo E Jankevics S Klein-Hessling T Twardzik A Avots, Biochim Biophys Acta 2000 1498 1 18
9. Transcriptional regulation by calcium, calcineurin, and NFAT. PG Hogan L Chen J Nardone A Rao, Genes Dev 2003 17 2205 2232
10. NFAT proteins: key regulators of T-cell development and function. F Macian, Nat Rev Immunol 2005 5 472 484
11. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. J Yang B Rothermel RB Vega N Frey TA McKinsey EN Olson R Bassel-Duby RS Williams, Circ Res 2000 87 61 68
12. The downstream consequences of calcineurin inhibition. TD Batiuk PF Halloran, Transplant Proc 1997 29 1239 1240
13. Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. IA Graef F Chen L Chen A Kuo GR Crabtree, Cell 2001 105 863 875
14. Defective T cell development and function in calcineurin A beta-deficient mice. OF Bueno EB Brandt ME Rothenberg JD Molkentin, Proc Natl Acad Sci USA 2002 99 9398 9403
15. Concerted dephosphorylation of the transcription factor NFAT1 induces a conformational switch that regulates transcriptional activity. H Okamura J Aramburu C Garcia-Rodriguez JP Viola A Raghavan M Tahiliani X Zhang J Qin PG Hogan A Rao, Mol Cell 2000 6 539 550
16. Interaction of calcineurin with a domain of the transcription factor NFAT1 that controls nuclear import. C Luo KT Shaw A Raghavan J Aramburu F Garcia-Cozar BA Perrino PG Hogan A Rao, Proc Natl Acad Sci USA 1996 93 8907 8912
17. Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1. J Zhu F Shibasaki R Price JC Guillemot T Yano V Dotsch G Wagner P Ferrara F McKeon, Cell 1998 93 851 861
18. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. CR Beals CM Sheridan CW Turck P Gardner GR Crabtree, Science 1997 275 1930 1934
19. A conserved docking motif for CK1 binding controls the nuclear localization of NFAT1. H Okamura C Garcia-Rodriguez H Martinson J Qin DM Virshup A Rao, Mol Cell Biol 2004 24 4184 4195
20. Two independent calcineurin-binding regions in the N-terminal domain of murine NF-ATx1 recruit calcineurin to murine NF-ATx1. J Liu ES Masuda L Tsuruta N Arai K Arai, J Immunol 1999 162 4755 4761
21. Selective inhibition of NFAT activation by a peptide spanning the calcineurin targeting site of NFAT. J Aramburu F Garcia-Cozar A Raghavan H Okamura A Rao PG Hogan, Mol Cell 1998 1 627 637
22. Two-site interaction of nuclear factor of activated T cells with activated calcineurin. FJ Garcia-Cozar H Okamura JF Aramburu KT Shaw L Pelletier R Showalter E Villafranca A Rao, J Biol Chem 1998 273 23877 23883
23. Blockade of NFAT activation by the second calcineurin binding site. S Martinez-Martinez A Rodriguez MD Lopez-Maderuelo I Ortega-Perez J Vazquez JM Redondo, J Biol Chem 2006 281 6227 6235
24. A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants. A Rodriguez J Roy S Martinez-Martinez MD Lopez-Maderuelo P Nino-Moreno L Orti D Pantoja-Uceda A Pineda-Lucena MS Cyert JM Redondo, Mol Cell 2009 33 616 626
25. Structure of calcineurin in complex with PVIVIT peptide: portrait of a low-affinity signalling interaction. H Li L Zhang A Rao SC Harrison PG Hogan, J Mol Biol 2007 369 1296 1306
26. A conserved docking site modulates substrate affinity for calcineurin, signaling output, and in vivo function. J Roy H Li PG Hogan MS Cyert, Mol Cell 2007 25 889 901
27. Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B. B Frantz EC Nordby G Bren N Steffan CV Paya RL Kincaid MJ Tocci SJ O'Keefe EA O'Neill, Embo J 1994 13 861 870
28. The calcium/calmodulin-dependent protein phosphatase calcineurin is the major Elk-1 phosphatase. T Sugimoto S Stewart KL Guan, J Biol Chem 1997 272 29415 29418
29. Calcium oscillations increase the efficiency and specificity of gene expression. RE Dolmetsch K Xu RS Lewis, Nature 1998 392 933 936
30. Calcineurin activates NF-kappaB in skeletal muscle C2C12 cells. H Alzuherri KC Chang, Cell Signal 2003 15 471 478
31. NF-kappaB activation by depolarization of skeletal muscle cells depends on ryanodine and IP3 receptor-mediated calcium signals. JA Valdes J Hidalgo JL Galaz N Puentes M Silva E Jaimovich MA Carrasco, Am J Physiol Cell Physiol 2007 292 1960 1970
32. Elevating calcium in Th2 cells activates multiple pathways to induce IL-4 transcription and mRNA stabilization. L Guo JF Urban J Zhu WE Paul, J Immunol 2008 181 3984 3993
33. Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point. Q Liu JC Busby JD Molkentin, Nat Cell Biol 2009 11 154 161
34. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. J Ninomiya-Tsuji K Kishimoto A Hiyama J Inoue Z Cao K Matsumoto, Nature 1999 398 252 256
35. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. JP Pearl J Parris DA Hale SC Hoffmann WB Bernstein KL McCoy SJ Swanson RB Mannon M Roederer AD Kirk, Am J Transplant 2005 5 465 474
36. Controlling the generation and function of human CD8+ memory T cells in vitro with immunosuppressants. DL Jones SH Sacks W Wong, Transplantation 2006 82 1352 1361
37. Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy. AL Taylor CJ Watson JA Bradley, Crit Rev Oncol Hematol 2005 56 23 46
38. Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis. MM El-Batawy MA Bosseila HM Mashaly VS Hafez, J Dermatol Sci 2009 54 76 87
39. Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis. C Brandt V Pavlovic A Radbruch M Worm R Baumgrass, Allergy 2009 64 1588 1596
40. Calcineurin: form and function. F Rusnak P Mertz, Physiol Rev 2000 80 1483 1521
41. Molecular genetic analysis of the calcineurin signaling pathways. R Sugiura SO Sio H Shuntoh T Kuno, Cell Mol Life Sci 2001 58 278 288
42. Biological effects of cyclosporin A: a new antilymphocytic agent. JF Borel C Feurer HU Gubler H Stahelin, Agents Actions 1976 6 468 475
43. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. RY Calne K Rolles DJ White S Thiru DB Evans P McMaster DC Dunn GN Craddock RG Henderson S Aziz P Lewis, Lancet 1979 2 1033 1036
44. The use of cyclosporin A and prednisone in cadaver kidney transplantation. TE Starzl R Weil 3rd S Iwatsuki G Klintmalm GP Schroter LJ Koep Y Iwaki PI Terasaki KA Porter, Surg Gynecol Obstet 1980 151 17 26
45. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. T Kino H Hatanaka M Hashimoto M Nishiyama T Goto M Okuhara M Kohsaka H Aoki H Imanaka, J Antibiot (Tokyo) 1987 40 1249 1255
46. FK 506 for liver, kidney, and pancreas transplantation. TE Starzl S Todo J Fung AJ Demetris R Venkataramman A Jain, Lancet 1989 2 1000 1004
47. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. J Liu JD Farmer Jr WS Lane J Friedman I Weissman SL Schreiber, Cell 1991 66 807 815
48. The mechanism of action of cyclosporin A and FK506. SL Schreiber GR Crabtree, Immunol Today 1992 13 136 142
49. Immunophilins: for the love of proteins. S Barik, Cell Mol Life Sci 2006 63 2889 2900
50. FKBP family proteins: immunophilins with versatile biological functions. CB Kang Y Hong S Dhe-Paganon HS Yoon, Neurosignals 2008 16 318 325
51. X-ray structure of calcineurin inhibited by the immunophilin- immunosuppressant FKBP12-FK506 complex. JP Griffith JL Kim EE Kim MD Sintchak JA Thomson MJ Fitzgibbon MA Fleming PR Caron K Hsiao MA Navia, Cell 1995 82 507 522
52. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. CR Kissinger HE Parge DR Knighton CT Lewis LA Pelletier A Tempczyk VJ Kalish KD Tucker RE Showalter EW Moomaw, et al. Nature 1995 378 641 644
53. Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes. Q Huai HY Kim Y Liu Y Zhao A Mondragon JO Liu H Ke, Proc Natl Acad Sci USA 2002 99 12037 12042
54. Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin. L Jin SC Harrison, Proc Natl Acad Sci USA 2002 99 13522 13526
55. Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B. SK Swanson T Born LD Zydowsky H Cho HY Chang CT Walsh F Rusnak, Proc Natl Acad Sci USA 1992 89 3741 3745
56. Mechanism for the paradoxical inhibition and stimulation of calcineurin by the immunosuppresive drug tacrolimus (FK506). M Yin RS Ochs, Arch Biochem Biophys 2003 419 207 213
57. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. RE Handschumacher MW Harding J Rice RJ Drugge DW Speicher, Science 1984 226 544 547
58. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. JJ Siekierka SH Hung M Poe CS Lin NH Sigal, Nature 1989 341 755 757
59. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. MW Harding A Galat DE Uehling SL Schreiber, Nature 1989 341 758 760
60. Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-kappaB. K Kalli C Huntoon M Bell DJ McKean, Mol Cell Biol 1998 18 3140 3148
61. Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. Y Aoki PN Kao, Antimicrob Agents Chemother 1999 43 2678 2684
62. Regulation of IkB alpha phosphorylation by PKC- and Ca(2+)-dependent signal transduction pathways. NM Steffan GD Bren B Frantz MJ Tocci EA O'Neill CV Paya, J Immunol 1995 155 4685 4691
63. The immunosuppressive drugs cyclosporin A and tacrolimus inhibit membrane depolarization-induced CREB transcriptional activity at the coactivator level. E Oetjen KM Thoms Y Laufer D Pape R Blume P Li W Knepel, Br J Pharmacol 2005 144 982 993
64. Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells. R Marienfeld M Neumann S Chuvpilo C Escher B Kneitz A Avots A Schimpl E Serfling, Eur J Immunol 1997 27 1601 1609
65. Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation. S Meyer NG Kohler A Joly, FEBS Lett 1997 413 354 358 (Pubitemid 27353299)
66. Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients. P Nickel F Presber G Bold D Biti C Schonemann SG Tullius HD Volk P Reinke, Transplantation 2004 78 1640 1646
67. Calcineurin inhibitor nephrotoxicity. M Naesens DR Kuypers M Sarwal, Clin J Am Soc Nephrol 2009 4 481 508
68. Manipulating immune responses with immunosuppressive agents that target NFAT. A Kiani A Rao J Aramburu, Immunity 2000 12 359 372
69. Branches on the alpha-C atom of cyclosporin A residue 3 result in direct calcineurin inhibition and rapid cyclophilin 18 binding. Y Zhang R Baumgrass M Schutkowski G Fischer, Chembiochem 2004 5 1006 1009
70. A study of the correlation between cyclophilin binding and in vitro immunosuppressive activity of cyclosporine A and analogues. PL Durette J Boger F Dumont R Firestone RA Frankshun SL Koprak CS Lin MR Melino AA Pessolano J Pisano, et al. Transplant Proc 1988 20 51 57
71. Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A? NH Sigal F Dumont P Durette JJ Siekierka L Peterson DH Rich BE Dunlap MJ Staruch MR Melino SL Koprak, et al. J Exp Med 1991 173 619 628
72. Immunosuppressive activity of [MeBm2t]1-, D-diaminobutyryl-8-, and D-diaminopropyl-8-cyclosporin analogues correlates with inhibition of calcineurin phosphatase activity. PA Nelson Y Akselband A Kawamura M Su RD Tung DH Rich V Kishore SL Rosborough MT DeCenzo DJ Livingston, et al. J Immunol 1993 150 2139 2147
73. Substitution in position 3 of cyclosporin A abolishes the cyclophilin-mediated gain-of-function mechanism but not immunosuppression. R Baumgrass Y Zhang F Erdmann A Thiel M Weiwad A Radbruch G Fischer, J Biol Chem 2004 279 2470 2479
74. Synthesis, conformation, and immunosuppressive activities of three analogues of cyclosporin A modified in the 1-position. JD Aebi DT Deyo CQ Sun D Guillaume B Dunlap DH Rich, J Med Chem 1990 33 999 1009 (Pubitemid 20085905)
75. ISA(TX)247: a novel calcineurin inhibitor. L Aspeslet D Freitag D Trepanier M Abel S Naicker N Kneteman R Foster R Yatscoff, Transplant Proc 2001 33 1048 1051
76. The novel calcineurin inhibitor ISA247: a more potent immunosuppressant than cyclosporine in vitro. T Birsan C Dambrin DG Freitag RW Yatscoff RE Morris, Transpl Int 2005 17 767 771
77. Amelioration of accelerated collagen induced arthritis by a novel calcineurin inhibitor, ISA(TX)247. WP Maksymowych GS Jhangri L Aspeslet MD Abel DJ Trepanier S Naicker DG Freitag BL Cooper RT Foster RW Yatscoff, J Rheumatol 2002 29 1646 1652
78. Voclosporin (ISA247) for plaque psoriasis. P Naidoo V Rambiritch, Lancet 2008 372 888 889 author reply 889
79. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin. FJ Dumont MJ Staruch SL Koprak JJ Siekierka CS Lin R Harrison T Sewell VM Kindt TR Beattie M Wyvratt, et al. J Exp Med 1992 176 751 760
80. The neuroprotective actions of FK506 binding protein ligands: neuronal survival is triggered by de novo RNA synthesis, but is independent of inhibition of JNK and calcineurin. A Klettner R Baumgrass Y Zhang G Fischer E Burger T Herdegen K Mielke, Brain Res Mol Brain Res 2001 97 21 31
81. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. J Liu MW Albers TJ Wandless S Luan DG Alberg PJ Belshaw P Cohen C MacKintosh CB Klee SL Schreiber, Biochemistry 1992 31 3896 3901
82. A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology. M Grassberger T Baumruker A Enz P Hiestand T Hultsch F Kalthoff W Schuler M Schulz FJ Werner A Winiski, et al. Br J Dermatol 1999 141 264 273
83. A tacrolimus-related immunosuppressant with biochemical properties distinct from those of tacrolimus. LB Peterson JG Cryan R Rosa MM Martin MB Wilusz PJ Sinclair F Wong JN Parsons SJ O'Keefe WH Parsons, et al. Transplantation 1998 65 10 18
84. A tacrolimus-related immunosuppressant with reduced toxicity. FJ Dumont S Koprak MJ Staruch A Talento G Koo C DaSilva PJ Sinclair F Wong J Woods J Barker, et al. Transplantation 1998 65 18 26
85. Chemistry and biology of the immunophilins and their immunosuppressive ligands. SL Schreiber, Science 1991 251 283 287
86. Immunoregulatory functions of mTOR inhibition. AW Thomson HR Turnquist G Raimondi, Nat Rev Immunol 2009 9 324 337
87. Minimizing the risk of posttransplant malignancy. JM Campistol, Transplantation 2009 87 19 22
88. 4-(Fluoromethyl)phenyl phosphate acts as a mechanism-based inhibitor of calcineurin. TL Born JK Myers TS Widlanski F Rusnak, J Biol Chem 1995 270 25651 25655
89. Inhibition of calcineurin by the tyrphostin class of tyrosine kinase inhibitors. BL Martin, Biochem Pharmacol 1998 56 483 488
90. Synthesis and biological evaluation of norcantharidin analogues: towards PP1 selectivity. SG Stewart TA Hill J Gilbert SP Ackland JA Sakoff A McCluskey, Bioorg Med Chem 2007 15 7301 7310
91. Use of protein phosphatase inhibitors. DC Weiser S Shenolikar, Curr Protoc Protein Sci 2003 Chapter 13 Unit 13 10
92. Class II pyrethroids: noninhibitors calcineurin. A Enz E Pombo-Villar, Biochem Pharmacol 1997 54 321 323
93. Pyrethroid insecticides as phosphatase inhibitors. KL Fakata SA Swanson RL Vorce PM Stemmer, Biochem Pharmacol 1998 55 2017 2022
94. Kaempferol: a new immunosuppressant of calcineurin. H Wang CL Zhou H Lei SD Zhang J Zheng Q Wei, IUBMB Life 2008 60 549 554
95. Studies on the interactions of kaempferol to calcineurin by spectroscopic methods and docking. H Lei Y Qi ZG Jia WL Lin Q Wei, Biochim Biophys Acta 2009 1794 1269 1275
96. Inhibitory effects of flavonoids on TNF-alpha-induced IL-8 gene expression in HEK 293 cells. S Lee YJ Kim S Kwon Y Lee SY Choi J Park HJ Kwon, BMB Rep 2009 42 265 270
97. Barbiturates directly inhibit the calmodulin/calcineurin complex: a novel mechanism of inhibition of nuclear factor of activated T cells. M Humar SE Pischke T Loop A Hoetzel R Schmidt C Klaas HL Pahl KK Geiger BH Pannen, Mol Pharmacol 2004 65 350 361
98. Repression of T-cell function by thionamides is mediated by inhibition of the activator protein-1/nuclear factor of activated T-cells pathway and is associated with a common structure. M Humar H Dohrmann P Stein N Andriopoulos U Goebel B Heimrich M Roesslein R Schmidt CI Schwer A Hoetzel, et al. Mol Pharmacol 2007 72 1647 1656
99. Thiopental inhibits the activation of nuclear factor kappaB. T Loop Z Liu M Humar A Hoetzel A Benzing HL Pahl KK Geiger JP BH, Anesthesiology 2002 96 1202 1213
100. The effects of anesthesia with thiopental on T lymphocyte responses to antigen and mitogens in vivo and in vitro. C Correa-Sales CE Tosta LV Rizzo, Int J Immunopharmacol 1997 19 117 128
101. Structure-based design of a highly selective catalytic site-directed inhibitor of Ser/Thr protein phosphatase 2B (calcineurin). Y Baba N Hirukawa N Tanohira M Sodeoka, J Am Chem Soc 2003 125 9740 9749
102. Optically active cantharidin analogues possessing selective inhibitory activity on Ser/Thr protein phosphatase 2B (calcineurin): implications for the binding mode. Y Baba N Hirukawa M Sodeoka, Bioorg Med Chem 2005 13 5164 5170
103. Gossypol inhibits calcineurin phosphatase activity at multiple sites. NJ Carruthers MK Dowd PM Stemmer, Eur J Pharmacol 2007 555 106 114
104. The immunosuppressive effect of gossypol in mice is mediated by inhibition of lymphocyte proliferation and by induction of cell apoptosis. WB Xu LH Xu HS Lu DY Ou-Yang HJ Shi JF Di XH He, Acta Pharmacol Sin 2009 30 597 604
105. The calcineurin inhibitor gossypol impairs growth, cell signalling and development in Dictyostelium discoideum. B Weissenmayer K Boeckeler A Lahrz R Mutzel, FEMS Microbiol Lett 2005 242 19 25
106. Substrate and cofactor specificity and selective inhibition of lactate dehydrogenase from the malarial parasite P. falciparum. MS Gomez RC Piper LA Hunsaker RE Royer LM Deck MT Makler DL Vander Jagt, Mol Biochem Parasitol 1997 90 235 246
107. Gossypol modification of Ala-1 of secreted phospholipase A2: a probe for the kinetic effects of sulfate glycoconjugates. BZ Yu J Rogers G Ranadive S Baker DC Wilton R Apitz-Castro MK Jain, Biochemistry 1997 36 12400 12411
108. Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol. RC Adlakha CL Ashorn D Chan LA Zwelling, Cancer Res 1989 49 2052 2058
109. p53 transactivation of the HIV-1 long terminal repeat is blocked by PD 14 a calcineurin-inhibitor with anti-HIV properties. A Gualberto G Marquez M Carballo GL Youngblood SW Hunt 3rd AS Baldwin F Sobrino, J Biol Chem 1998 273 12 7088 7093
110. Dibefurin, a novel fungal metabolite inhibiting calcineurin phosphatase activity. GM Brill U Premachandran JP Karwowski R Henry DK Cwik LM Traphagen PE Humphrey M Jackson JJ Clement NS Burres, et al. J Antibiot (Tokyo) 1996 49 124 128
111. Inhibiting the calcineurin-NFAT (nuclear factor of activated T cells) signaling pathway with a regulator of calcineurin-derived peptide without affecting general calcineurin phosphatase activity. MC Mulero A Aubareda M Orzaez J Messeguer E Serrano-Candelas S Martinez-Hoyer A Messeguer E Perez-Paya M Perez-Riba, J Biol Chem 2009 284 9394 9401
112. Systematic discovery of multicomponent therapeutics. AA Borisy PJ Elliott NW Hurst MS Lee J Lehar ER Price G Serbedzija GR Zimmermann MA Foley BR Stockwell CT Keith, Proc Natl Acad Sci USA 2003 100 7977 7982
113. Inhibition of calcineurin-NFAT signaling by the pyrazolopyrimidine compound NCI3. M Sieber M Karanik C Brandt C Blex M Podtschaske F Erdmann R Rost E Serfling J Liebscher M Patzel, et al. Eur J Immunol 2007 37 2617 2626
114. Selective inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with small organic molecules. MH Roehrl S Kang J Aramburu G Wagner A Rao PG Hogan, Proc Natl Acad Sci USA 2004 101 7554 7559
115. Inhibition of the calcineurin-NFAT interaction by small organic molecules reflects binding at an allosteric site. S Kang H Li A Rao PG Hogan, J Biol Chem 2005 280 37698 37706
116. 3,5-Bis(trifluoromethyl)pyrazoles: a novel class of NFAT transcription factor regulator. SW Djuric NY BaMaung A Basha H Liu JR Luly DJ Madar RJ Sciotti NP Tu FL Wagenaar PE Wiedeman, et al. J Med Chem 2000 43 2975 2981
117. TH1 and TH2 cytokine inhibition by 3,5-bis(trifluoromethyl)pyrazoles, a novel class of immunomodulators. Y Chen ML Smith GX Chiou S Ballaron MP Sheets E Gubbins U Warrior J Wilkins C Surowy M Nakane, et al. Cell Immunol 2002 220 134 142
118. Potent inhibition of NFAT activation and T cell cytokine production by novel low molecular weight pyrazole compounds. JM Trevillyan XG Chiou YW Chen SJ Ballaron MP Sheets ML Smith PE Wiedeman U Warrior J Wilkins EJ Gubbins, et al. J Biol Chem 2001 276 48118 48126
119. A pyrazole derivative, YM-58483 potently inhibits store-operated sustained Ca2+ influx and IL-2 production in T lymphocytes. J Ishikawa K Ohga T Yoshino R Takezawa A Ichikawa H Kubota T Yamada, J Immunol 2003 170 9 4441 4449
120. Potent inhibition of Ca2+ release-activated Ca2+ channels and T-lymphocyte activation by the pyrazole derivative BTP2. C Zitt B Strauss EC Schwarz N Spaeth G Rast A Hatzelmann M Hoth, J Biol Chem 2004 279 12427 12437
121. A pyrazole derivative potently inhibits lymphocyte Ca2+ influx and cytokine production by facilitating transient receptor potential melastatin 4 channel activity. R Takezawa H Cheng A Beck J Ishikawa P Launay H Kubota JP Kinet A Fleig T Yamada R Penner, Mol Pharmacol 2006 69 1413 1420
122. YM-58483 a selective CRAC channel inhibitor, prevents antigen-induced airway eosinophilia and late phase asthmatic responses via Th2 cytokine inhibition in animal models. T Yoshino J Ishikawa K Ohga T Morokata R Takezawa H Morio Y Okada K Honda T Yamada, Eur J Pharmacol 2007 560 2-3 225 233
123. Characterization of YM-58483/BTP2, a novel store-operated Ca2+ entry blocker, on T cell-mediated immune responses in vivo. K Ohga R Takezawa Y Arakida Y Shimizu J Ishikawa, Int Immunopharmacol 2008 8 1787 1792
124. Potent inhibition of store-operated Ca2+ influx and superoxide production in HL60 cells and polymorphonuclear neutrophils by the pyrazole derivative BTP2. N Steinckwich JP Frippiat MJ Stasia M Erard R Boxio C Tankosic I Doignon O Nusse, J Leukoc Biol 2007 81 1054 1064
125. Preliminary in vivo pharmacokinetic and pharmacodynamic evaluation of a novel calcineurin-independent inhibitor of NFAT. T Birsan C Dambrin KC Marsh W Jacobsen SW Djuric KW Mollison U Christians GW Carter RE Morris, Transpl Int 2004 17 145 150
126. Novel blocker of NFAT activation inhibits IL-6 production in human myometrial arteries and reduces vascular smooth muscle cell proliferation. LM Nilsson ZW Sun J Nilsson I Nordstrom YW Chen JD Molkentin D Wide-Swensson P Hellstrand ML Lydrup MF Gomez, Am J Physiol Cell Physiol 2007 292 1167 1178
127. Nuclear translocation of calcineurin Abeta but not calcineurin Aalpha by platelet-derived growth factor in rat aortic smooth muscle. RI Jabr AJ Wilson MH Riddervold AH Jenkins BA Perrino LH Clapp, Am J Physiol Cell Physiol 2007 292 2213 2225
128. The immunosuppressor st1959 a 3,5-diaryl-s-triazole derivative, inhibits T cell activation by reducing NFAT nuclear residency. R Lindstedt V Ruggiero DA D'Alessio S Manganello F Petronzelli MA Stasi S Vendetti A Assandri P Carminati R De Santis, Int J Immunopathol Pharmacol 2009 22 1 29 42
129. Immunological profile of DL111-IT, a new immunosuppressant agent. G Mistrello G Galliani A Assandri S Filippeschi L Bassi, Immunopharmacology 1985 10 163 169
130. Efficacy of a nanocochleate-encapsulated 3,5-diaryl-s-triazole derivative in a murine model of graft-versus-host disease. S Campo B Arseni S Rossi V D'Alessio R Lu J Ngoje PL Ahl S Bonitz R Mannino D Di Mitri, et al. Transplantation 2008 86 171 175
131. Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. ED Hogestatt BA Jonsson A Ermund DA Andersson H Bjork JP Alexander BF Cravatt AI Basbaum PM Zygmunt, J Biol Chem 2005 280 31405 31412
132. The acetaminophen-derived bioactive N-acylphenolamine AM404 inhibits NFAT by targeting nuclear regulatory events. FJ Caballero CM Navarrete S Hess BL Fiebich G Appendino A Macho E Munoz R Sancho, Biochem Pharmacol 2007 73 1013 1023
133. UR-1505 - a new salicylate, blocks T cell activation through nuclear factor of activated T cells. J Roman AF de Arriba S Barron P Michelena M Giral M Merlos E Bailon M Comalada J Galvez A Zarzuelo I Ramis, Mol Pharmacol 2007 72 2 269 279
134. The new salicylate derivative UR-1505 modulates the Th2/humoral response in a dextran sodium sulphate model of colitis that resembles ulcerative colitis. E Bailon J Roman I Ramis P Michelena D Balsa M Merlos A Zarzuelo J Galvez M Comalada, J Pharmacol Sci 2009 109 315 318
135. A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription. M Aceves A Duenas C Gomez E San Vicente MS Crespo C Garcia-Rodriguez, J Immunol 2004 173 5721 5729
136. Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells. P Proksch M Giaisi MK Treiber K Palfi A Merling H Spring PH Krammer M Li-Weber, J Immunol 2005 174 7075 7084
137. FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. SJ O'Keefe J Tamura RL Kincaid MJ Tocci EA O'Neill, Nature 1992 357 692 694
138. The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway. L Vega Lde E Munoz MA Calzado K Lieb E Candelario-Jalil H Gschaidmeir L Farber W Mueller T Stratz BL Fiebich, Biochem Pharmacol 2005 70 369 380
139. Anti-inflammatory effects of 5-HT receptor antagonist, tropisetron on experimental colitis in rats. K Mousavizadeh R Rahimian G Fakhfouri FS Aslani P Ghafourifar, Eur J Clin Invest 2009 39 375 383
140. Chemical genetics to identify NFAT inhibitors: potential of targeting calcium mobilization in immunosuppression. N Venkatesh Y Feng B DeDecker P Yacono D Golan T Mitchison F McKeon, Proc Natl Acad Sci USA 2004 101 8969 8974
141. Functional characterization of novel IL-2 transcriptional inhibitors. Y Baine BM Stankunas P Miller C Hobbs L Tiberio J Koch K Yoon D Sawutz C Surowy, J Immunol 1995 154 3667 3677
142. Calcineurin is a calmodulin-dependent protein phosphatase. SD Yang EA Tallant WY Cheung, Biochem Biophys Res Commun 1982 106 1419 1425
143. Calcineurin protein phosphatase activity in peripheral blood lymphocytes. F Rusnak AH Beressi A Haddy A Tefferi, Bone Marrow Transplant 1996 17 309 313
144. Calmodulin, a junction between two independent immunosuppressive pathways in Jurkat T cells. C Aussel JP Breittmayer C Pelassy A Bernard, J Biol Chem 1995 270 8032 8036
145. Oral administration of 1, 4-aryl-2-mercaptoimidazole (KRM-III) inhibits T cell proliferation and reduces clinical severity in murine experimental autoimmune encephalomyelitis model. EJ Jung M Hur YL Kim GH Lee J Kim I Kim M Lee HK Han MS Kim S Hwang, et al. J Pharmacol Exp Ther 2009
146. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors. N Marquez R Sancho A Macho MA Calzado BL Fiebich E Munoz, J Pharmacol Exp Ther 2004 308 993 1001
147. Propolis and some of its constituents down-regulate DNA synthesis and inflammatory cytokine production but induce TGF-beta1 production of human immune cells. S Ansorge D Reinhold U Lendeckel, Z Naturforsch [C] 2003 58 580 589
148. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. K Natarajan S Singh TR Burke Jr D Grunberger BB Aggarwal, Proc Natl Acad Sci USA 1996 93 9090 9095
149. 3-(13-Hydroxytridecyl)-1-[13-(3-pyridyl)tridecyl]pyridinium chloride (YM-53792), a novel inhibitor of NF-AT activation. S Kuromitsu M Fukunaga AC Lennard Y Masuho S Nakada, Biochem Pharmacol 1997 54 999 1005
150. Novel inhibitors of the nuclear factor of activated T cells (NFAT)-mediated transcription of beta-galactosidase: potential immunosuppressive and antiinflammatory agents. WF Michne JD Schroeder JW Guiles AM Treasurywala CA Weigelt MF Stansberry E McAvoy CR Shah Y Baine DG Sawutz, et al. J Med Chem 1995 38 2557 2569
151. Monocarboxylate transporter MCT1 is a target for immunosuppression. CM Murray R Hutchinson JR Bantick GP Belfield AD Benjamin D Brazma RV Bundick ID Cook RI Craggs S Edwards, et al. Nat Chem Biol 2005 1 371 376
152. Simple aromatics identified with a NFAT-lacZ transcription assay for the detection of immunosuppressants. NS Burres U Premachandran S Hoselton D Cwik JE Hochlowski Q Ye GN Sunga JP Karwowski M Jackson DN Whittern, et al. J Antibiot (Tokyo) 1995 48 380 386
153. Immune-suppressive activity of punicalagin via inhibition of NFAT activation. SI Lee BS Kim KS Kim S Lee KS Shin JS Lim, Biochem Biophys Res Commun 2008 371 799 803
154. Imperatorin inhibits T-cell proliferation by targeting the transcription factor NFAT. N Marquez R Sancho M Ballero P Bremner G Appendino BL Fiebich M Heinrich E Munoz, Planta Med 2004 70 1016 1021
155. Quinolone alkaloids with inhibitory activity against nuclear factor of activated T cells from the fruits of Evodia rutaecarpa. HZ Jin JH Lee D Lee HS Lee YS Hong YH Kim JJ Lee, Biol Pharm Bull 2004 27 926 928
156. Phenolic constituents with inhibitory activity against NFAT transcription from Desmos chinensis. PV Kiem CV Minh HT Huong JJ Lee IS Lee YH Kim, Arch Pharm Res 2005 28 1345 1349
157. New inhibitor against nuclear factor of activated T cells transcription from Ribes fasciculatum var. chinense. NT Dat XF Cai Q Shen IS Lee YH Kim, Chem Pharm Bull (Tokyo) 2005 53 114 117
158. Triterpenoids from Acanthopanax koreanum root and their inhibitory activities on NFAT transcription. XF Cai IS Lee G Shen NT Dat JJ Lee YH Kim, Arch Pharm Res 2004 27 825 828 (Pubitemid 43073701)
159. Inhibitory lignans against NFAT transcription factor from Acanthopanax koreanum. XF Cai IS Lee NT Dat G Shen JS Kang DH Kim YH Kim, Arch Pharm Res 2004 27 738 741 (Pubitemid 43086217)
160. Diterpenoids with inhibitory activity against NFAT transcription factor from Acanthopanax koreanum. XF Cai IS Lee NT Dat G Shen YH Kim, Phytother Res 2004 18 677 680 (Pubitemid 39329722)
161. Oleanane triterpenoids with inhibitory activity against NFAT transcription factor from Liquidambar formosana. NT Dat IS Lee XF Cai G Shen YH Kim, Biol Pharm Bull 2004 27 426 428 (Pubitemid 41685493)
162. Lignans with inhibitory activity against NFAT transcription from Schisandra chinensis. IS Lee HK Lee NT Dat MS Lee JW Kim DS Na YH Kim, Planta Med 2003 69 63 64
163. Competitive inhibition of calcineurin phosphatase activity by its autoinhibitory domain. JK Sagoo DA Fruman S Wesselborg CT Walsh BE Bierer, Biochem J 1996 320 Pt 3 879 884
164. Identification of an autoinhibitory domain in calcineurin. Y Hashimoto BA Perrino TR Soderling, J Biol Chem 1990 265 1924 1927
165. Calcium regulation of calcineurin phosphatase activity by its B subunit and calmodulin. Role of the autoinhibitory domain. BA Perrino LY Ng TR Soderling, J Biol Chem 1995 270 340 346
166. Regulation of calcineurin phosphatase activity by its autoinhibitory domain. BA Perrino, Arch Biochem Biophys 1999 372 159 165
167. Inhibition of excitatory neuronal cell death by cell-permeable calcineurin autoinhibitory peptide. H Terada M Matsushita YF Lu T Shirai ST Li K Tomizawa A Moriwaki S Nishio I Date T Ohmoto H Matsui, J Neurochem 2003 87 1145 1151
168. Caerulein-induced intracellular pancreatic zymogen activation is dependent on calcineurin. SZ Husain WM Grant FS Gorelick MH Nathanson AU Shah, Am J Physiol Gastrointest Liver Physiol 2007 292 1594 1599
169. Ca2+/calcineurin signalling in cells of the immune system. S Feske H Okamura PG Hogan A Rao, Biochem Biophys Res Commun 2003 311 1117 1132
170. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. J Aramburu MB Yaffe C Lopez-Rodriguez LC Cantley PG Hogan A Rao, Science 1999 285 2129 2133
171. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. H Noguchi M Matsushita T Okitsu A Moriwaki K Tomizawa S Kang ST Li N Kobayashi S Matsumoto K Tanaka, et al. Nat Med 2004 10 305 309
172. Mapping the protein phosphatase-2B anchoring site on AKAP79. Binding and inhibition of phosphatase activity are mediated by residues 315-360. ML Dell'Acqua KL Dodge SJ Tavalin JD Scott, J Biol Chem 2002 277 48796 48802
173. Cain, a novel physiologic protein inhibitor of calcineurin. MM Lai PE Burnett H Wolosker S Blackshaw SH Snyder, J Biol Chem 1998 273 18325 18331
174. Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes. L Sun HD Youn C Loh M Stolow W He JO Liu, Immunity 1998 8 703 711
175. Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin 1 (or RCAN1) in disease. CD Harris G Ermak KJ Davies, Cell Mol Life Sci 2005 62 2477 2486
176. Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo. B Chan G Greenan F McKeon T Ellenberger, Proc Natl Acad Sci USA 2005 102 13075 13080
177. Functional characterization of the calcipressin 1 motif that suppresses calcineurin-mediated NFAT-dependent cytokine gene expression in human T cells. A Aubareda MC Mulero M Perez-Riba, Cell Signal 2006 18 1430 1438
178. The RCAN carboxyl end mediates calcineurin docking-dependent inhibition via a site that dictates binding to substrates and regulators. S Martinez-Martinez L Genesca A Rodriguez A Raya E Salichs F Were MD Lopez-Maderuelo JM Redondo S de la Luna, Proc Natl Acad Sci USA 2009 106 6117 6122
179. Domain architecture of the regulators of calcineurin (RCANs) and identification of a divergent RCAN in yeast. S Mehta H Li PG Hogan KW Cunningham, Mol Cell Biol 2009 29 2777 2793
180. A second calcineurin binding site on the NFAT regulatory domain. S Park M Uesugi GL Verdine, Proc Natl Acad Sci USA 2000 97 7130 7135
181. Inhibition of NFATx activation by an oligopeptide: disrupting the interaction of NFATx with calcineurin. J Liu K Arai N Arai, J Immunol 2001 167 2677 2687
182. A new calcineurin inhibition domain in Cabin1. H Jang EJ Cho HD Youn, Biochem Biophys Res Commun 2007 359 129 135
183. A conserved family of calcineurin regulators. TJ Kingsbury KW Cunningham, Genes Dev 2000 14 1595 1604
184. Multiple domains of MCIP1 contribute to inhibition of calcineurin activity. RB Vega J Yang BA Rothermel R Bassel-Duby RS Williams, J Biol Chem 2002 277 30401 30407
185. The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. M Boncristiano SR Paccani S Barone C Ulivieri L Patrussi D Ilver A Amedei MM D'Elios JL Telford CT Baldari, J Exp Med 2003 198 1887 1897
186. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. B Gebert W Fischer E Weiss R Hoffmann R Haas, Science 2003 301 1099 1102
187. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. MS Sundrud VJ Torres D Unutmaz TL Cover, Proc Natl Acad Sci USA 2004 101 7727 7732
188. Integrin subunit CD18 Is the T-lymphocyte receptor for the Helicobacter pylori vacuolating cytotoxin. X Sewald B Gebert-Vogl S Prassl I Barwig E Weiss M Fabbri R Osicka M Schiemann DH Busch M Semmrich, et al. Cell Host Microbe 2008 3 20 29
189. A viral mechanism for inhibition of the cellular phosphatase calcineurin. JE Miskin CC Abrams LC Goatley LK Dixon, Science 1998 281 562 565
190. A238L inhibits NF-ATc2, NF-kappa B, and c-Jun activation through a novel mechanism involving protein kinase C-theta-mediated up-regulation of the amino-terminal transactivation domain of p300. AG Granja ND Perkins Y Revilla, J Immunol 2008 180 2429 2442
191. Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation. S Matsuda F Shibasaki K Takehana H Mori E Nishida S Koyasu, EMBO Rep 2000 1 428 434
192. The viral protein A238L inhibits cyclooxygenase-2 expression through a nuclear factor of activated T cell-dependent transactivation pathway. AG Granja ML Nogal C Hurtado V Vila AL Carrascosa ML Salas M Fresno Y Revilla, J Biol Chem 2004 279 53736 53746
193. African swine fever virus protein A238L interacts with the cellular phosphatase calcineurin via a binding domain similar to that of NFAT. JE Miskin CC Abrams LK Dixon, J Virol 2000 74 9412 9420
194. Structure-based design of novel calcineurin (PP2B) inhibitors. JH Tatlock MA Linton XJ Hou CR Kissinger LA Pelletier RE Showalter A Tempczyk JE Villafranca, Bioorg Med Chem Lett 1997 7 1007 1012
195. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. C Bialojan A Takai, Biochem J 1988 256 283 290
196. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. DA Fruman CB Klee BE Bierer SJ Burakoff, Proc Natl Acad Sci USA 1992 89 3686 3690
197. Preparation and in vitro activities of naphthyl and indolyl ether derivatives of the FK-506 related immunosuppressive macrolide ascomycin. PJ Sinclair F Wong MJ Staruch GJ Wiederrecht WH Parsons F Dumont M Wyvratt, Bioorg Med Chem Lett 1996 6 2193 2196
198. Reversible inhibition of calcineurin by the polyphenolic aldehyde gossypol. R Baumgrass M Weiwad F Erdmann JO Liu D Wunderlich S Grabley G Fischer, J Biol Chem 2001 276 47914 47921